NCT07705321Active, not recruiting
Assessment of Retinal Microcirculation in Patients With Type 1 Diabetes Mellitus
Source: ClinicalTrials.gov · Last updated 15 Jul 2026
Brief summary (registry, in English)
Type 1 diabetes mellitus (T1DM) is associated with an increased lifetime risk of developing diabetic retinopathy, a leading cause of visual impairment among working-age adults worldwide. Retinal assessment plays a pivotal role in the management of patients with T1DM, as the retina provides a unique, non-invasive window into the body's microvascular circulation. Early detection of retinal abnormalities is essential because structural and microvascular changes may develop years before the onset of vision-threatening diabetic retinopathy or visual symptoms. Contemporary retinal imaging techniques, enable the quantitative evaluation of retinal microvasculature allowing the identification of subclinical retinal damage.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 6 Jul 2026
- Start date
- 1 Jun 2025
- Primary completion date
- 30 Aug 2026
- Lead sponsor
- University of Athens
- Diseases
- Type 1 diabetes, Diabetic eye disease
- NCT number
- NCT07705321
What you commit to
- Study type: Observational
- Planned participants: 100
- From 1 Jun 2025 to the primary completion date, 30 Aug 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- History of intraocular surgery within the previous 6 months.
Other illness
- Active uveitis or other intraocular inflammatory disease.
- History of ocular trauma.
Other
- Uncontrolled glaucoma
- High myopia (spherical equivalent refractive error \>5.0 diopters)
Who the study is looking for
- Adults aged 18 years or older.
- Diagnosis of Type 1 diabetes mellitus (T1DM) according to the American Diabetes Association (ADA) criteria.
- Ability and willingness to provide written informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| 2nd Department of Ophthalmology, Attikon University Hospital, National and Kapodistrian University of Athens Coordinator of this site? Confirm its status | Athens | Greece | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.